Patents by Inventor Manshiu Leung

Manshiu Leung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained Release Particulate Oral Dosage Forms of (R)-Baclofen and Methods of Treatment
    Publication number: 20100137442
    Abstract: Sustained release particulate oral dosage forms of (R)-baclofen prodrugs and methods of treating a disease comprising orally administering such dosage forms are disclosed.
    Type: Application
    Filed: February 1, 2008
    Publication date: June 3, 2010
    Applicant: XenoPort, Inc.
    Inventors: Srikonda SASTRY, Kenneth CUNDY, Manshiu LEUNG
  • Levodopa Prodrug Mesylate Hydrate
    Publication number: 20100099761
    Abstract: Crystalline (2R)-2-phenylcarbonyloxypropyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate mesylate, hydrate, methods of making the hydrate, pharmaceutical compositions containing the hydrate, and methods of using the hydrate to treat diseases or disorders such as Parkinson's disease are provided.
    Type: Application
    Filed: October 19, 2009
    Publication date: April 22, 2010
    Inventors: Sami Karaborni, Manshiu Leung, Chen Mao, Venkat R. Thalladi
  • Sustained Release Particulate Oral Dosage Forms of (R) Baclofen and Methods of Treatment
    Publication number: 20090197958
    Abstract: Sustained release particulate oral dosage forms of (R)-baclofen prodrugs and methods of treating a disease comprising orally administering such dosage forms are disclosed.
    Type: Application
    Filed: February 1, 2008
    Publication date: August 6, 2009
    Applicant: XenoPort, Inc.
    Inventors: Srikonsda SASTRY, Kenneth C. Cundy, Manshiu Leung
  • SUSTAINED RELEASE ORAL DOSAGE FORMS OF A PRODRUG OF R-BACLOFEN AND METHODS OF TREATMENT
    Publication number: 20080206332
    Abstract: Sustained release oral dosage forms of R-baclofen and methods of treating diseases comprising orally administering such dosage forms are disclosed.
    Type: Application
    Filed: January 10, 2008
    Publication date: August 28, 2008
    Inventors: David J. Kidney, Kenneth C. Cundy, Srikonda Sastry, Manshiu Leung
  • GABA analog prodrug sustained release oral dosage forms
    Publication number: 20060141034
    Abstract: Sustained release oral dosage forms of a gabapentin prodrug, 1-{[(?-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid, are disclosed. The dosage forms are useful for treating or preventing diseases and disorders for which gabapentin is therapeutically effective.
    Type: Application
    Filed: November 3, 2005
    Publication date: June 29, 2006
    Inventors: Kenneth Cundy, Srikonda Sastry, Manshiu Leung, Balaji Kadri, Paul Stach